seliciclib (Compound)

Synonyms:roscovitine, Seliciclib, 186692-46-6, R-Roscovitine, (R)-roscovitine, CYC202, CYC-202, CYC 202, Seliciclib [INN], 2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine, Seliciclib (Roscovitine), Roscovitine (Seliciclib,CYC202), (R)-2-((6-(Benzylamino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol, NSC-701554, AL-39256, ROSCOVITINE(Seliciclib), CHEMBL14762, 0ES1C2KQ94, CHEBI:45307, (2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol, (2R)-2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol, NSC701554, (2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol, (2R)-2-((6-benzylamino-9-(propan-2-yl)-9h-purin-2-yl)amino)butan-1-ol, RRC, Rosco, (2R)-2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol, NSC 701554, UNII-0ES1C2KQ94, 2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine, BMK1-E12, 1unl, 3ddq, (2R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol, 1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-, (2R)-, 1-Butanol, 2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, (2R)-, MFCD02266401, 2a4l, SELICICLIB [MI], BiomolKI_000048, 1-Butanol, (2R)-, BiomolKI2_000054, M02443, SELICICLIB [WHO-DD], CBiol_002016, Lopac0_001102, SCHEMBL94728, BSPBio_001078, KBioGR_000418, KBioSS_000418, MLS006011028, BDBM7533, cid_160355, GTPL6035, Roscovitine, >=98% (TLC), BCBcMAP01_000013, KBio2_000418, KBio2_002986, KBio2_005554, KBio3_000795, KBio3_000796, DTXSID20171928, EX-A052, BCPP000087, Bio1_000302, Bio1_000791, Bio1_001280, Bio2_000379, Bio2_000859, CC205, HMS1362F19, HMS1792F19, HMS1990F19, HMS3229N13, HMS3403F19, AMY10845, BCP01760, Roscovitine (Seliciclib, CYC202), HSCI1_000092, NSC800881, s1153, AKOS005146319, AC-2416, CCG-100652, DB06195, NSC-800881, IDI1_002134, Roscovitine - CAS 186692-46-6, SMP1_000266, 2,6,9-Trisubstituted purine deriv. 28, NCGC00094374-01, NCGC00094374-02, NCGC00094374-03, NCGC00094374-04, NCGC00094374-05, NCGC00094374-13, NCGC00094374-15, AS-56277, HY-30237, NCI60_036420, SMR004702823, SW220195-1, K00020, A813074, EN300-26484982, J-011999, J-524224, Q3494619, BRD-K07691486-001-03-1, BRD-K07691486-001-05-6, Z1741982636, (2R)-2-[[6-(benzylamino)-9-propan-2-yl-purin-2-yl]amino]butan-1-ol, (2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]-1-butanol, (2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-purin-2-yl]amino]butan-1-ol, (2R)-2-{[6-(benzylamino)-9-(1-methylethyl)-9H-purin-2-yl]amino}butan-1-ol, (R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol, 1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-, (R)-, 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]- 9H-purin-2-yl]amino]-(R)-1-butanol
Pubchem:PUBCHEM:160355
Id:f5bced78-1aa6-5383-b457-8b4ca7efd51e
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View seliciclib's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for seliciclib.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with seliciclib.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.